- Condition: Migraine Disorders
Interventions: Biological: ALD403; Biological: ALD403; Biological: Sumatriptan
Sponsors: Alder Biopharmaceuticals, Inc.; Alder Biopharmaceuticals, Inc.
Recruiting - verified April 2012 - Condition: Healthy Volunteers
Interventions: Drug: BMS-754807 (IGR-IR/IR Inhibitor); Drug: Metformin
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Completed - verified May 2012 - Condition: Polycystic Ovary Syndrome
Interventions: Drug: Moxonidine; Drug: Placebo
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute
Not yet recruiting - verified January 2012 - Conditions: Myelodysplastic Syndromes (MDS); Acute Myeloid Leukaemia (AML)
Intervention: Drug: Azacitidine and eltrombopag
Sponsors: Peter MacCallum Cancer Centre, Australia; Peter MacCallum Cancer Centre, Australia; GlaxoSmithKline; Celgene Corporation
Recruiting - verified December 2011 - Condition: Healthy
Interventions: Drug: BG00012 Dose 1; Drug: BG00012 Dose 2
Sponsors: Biogen Idec; Biogen Idec
Recruiting - verified March 2012 - Conditions: Meningococcal Disease; Meningococcal Meningitis
Intervention: Biological: Serogroup B meningococcal vaccine
Sponsors: Novartis; Novartis; Novartis Vaccines
Completed - verified January 2012 - Condition: Brain Injuries, Traumatic
Interventions: Drug: NNZ-2566; Drug: Placebo
Sponsors: Neuren Pharmaceuticals Limited; Neuren Pharmaceuticals Limited
Recruiting - verified March 2012 - Condition: Human Papillomavirus
Intervention:
Sponsors: The Alfred; The Alfred; Merck
Recruiting - verified August 2011 - Conditions: Depressive Disorder; Depression
Intervention: Behavioral: Mood Memo emails
Sponsors: Orygen Youth Health Research Centre; Orygen Youth Health Research Centre; National Health and Medical Research Council, Australia; University of Melbourne; Sidney Myer Fund
Recruiting - verified November 2011 - Condition: Healthy Volunteers
Interventions: Drug: BIIB023 - low dose IV Dose; Drug: BIIB023 - high dose IV Dose
Sponsors: Biogen Idec; Biogen Idec
Completed - verified March 2012 - Condition: Healthy Volunteers
Interventions: Drug: OZ439; Drug: OZ439 mesylate; Drug: OZ439 mesylate; Drug: OZ439
Sponsors: Medicines for Malaria Venture; Medicines for Malaria Venture; Nucleus Network Ltd; INC Research
Recruiting - verified April 2012 - Condition: Influenza Infection
Intervention: Biological: GSK Biologicals' investigational vaccine GSK1562902A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified January 2012 - Condition: Cat Allergy
Interventions: Biological: Intradermal Human Fcγ1-Fel d1 fusion protein; Biological: Positive Control - standardized cat hair allergenic extract (CAT); Biological: Positive Control - Histamine Prick; Biological: Negative Control - Intradermal Diluent
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Tunitas Therapeutics; National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN)
Terminated - verified July 2011 - Condition: Post-Operative Nausea and Vomiting (PONV)
Interventions: Drug: GW597599; Drug: Placebo
Sponsors: Octagon Research Solutions, Inc.; Octagon Research Solutions, Inc.
Completed - verified October 2011 - Conditions: Ulcerative Colitis; Crohn's Disease
Interventions: Drug: AMG 181; Other: Placebo for AMG 181
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Condition: Crohn's Disease
Intervention: Drug: AMG 139
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Condition: Prophylaxis of Ross River Virus Infection
Intervention: Biological: Ross River Virus Vaccine
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Active, not recruiting - verified October 2011 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Ulcerative Colitis
Intervention: Drug: Amg 181
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Condition: Pandemic H1N1 Influenza
Interventions: Biological: GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations); Biological: GSK Biologicals' investigational vaccine GSK2340273A (alternative formulations)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012 - Condition: Encephalitis
Interventions: Biological: IC51; Biological: IC51; Biological: IC51
Sponsors: Intercell AG; Intercell AG
Recruiting - verified January 2012 - Conditions: Positron-Emission Tomography; Multiple Sclerosis
Interventions: Drug: F-18 FEDAA1106 (BAY85-8101); Drug: F-18 FEDAA1106 (BAY85-8101)
Sponsors: Bayer; Bayer
Completed - verified April 2012 - Condition: Heart Failure
Intervention:
Sponsors: Monash University; Monash University; The Alfred
Active, not recruiting - verified October 2011 - Condition: Obesity
Intervention: Drug: ZGN-433
Sponsors: Zafgen, Inc.; Zafgen, Inc.
Completed - verified January 2012 - Conditions: Bacterial Infections; Staphylococcal Vaccines; Immunotherapy, Active; Staphylococcal Skin Infections; Staphylococcal Infections
Interventions: Biological: SA3Ag vaccine; Procedure: Blood draw; Procedure: Colonization swab samples; Biological: SA3Ag followed by Placebo; Procedure: Blood draw; Procedure: Colonization swab samples; Biological: Placebo; Procedure: Blood draw; Procedure: Colonization swab samples; Biological: SA3Ag with no booster in stage 2; Procedure: Blood draw; Procedure: Colonization swab samples; Procedure: Placebo with no booster in stage 2; Procedure: Blood draw; Procedure: Colonization swab samples
Sponsors: Pfizer; Pfizer
Completed - verified August 2011 - Conditions: QTc Evaluation; Electrocardiography
Interventions: Drug: Avelox (Moxifloxacin, BAY12-8039); Drug: Placebo
Sponsors: Bayer; Bayer
Completed - verified October 2011 - Condition: Meningococcal Disease
Intervention: Biological: MenACWY conjugate vaccine plus routine infant vaccines
Sponsors: Novartis; Novartis Vaccines
Completed - verified March 2012 - Condition: Brain Injuries, Traumatic
Interventions: Drug: NNZ-2566; Drug: Placebo
Sponsors: Neuren Pharmaceuticals Limited; Neuren Pharmaceuticals Limited
Completed - verified August 2011 - Conditions: Healthy; Obesity
Intervention: Drug: ghrelin
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute
Completed - verified December 2011 - Condition: Contraception
Intervention: Drug: Ethinylestradiol/Gestodene (BAY86-5016)
Sponsors: Bayer; Bayer
Completed - verified October 2011 - Condition: Contraception
Intervention: Drug: Levonorgestrel IUS (LCS, BAY86-5028)
Sponsors: Bayer; Bayer
Active, not recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Institute on Aging (NIA)
Recruiting - verified October 2011 - Condition: Central Arterial Pressure
Interventions: Drug: Ivabradine; Drug: Metoprolol; Drug: Placebo
Sponsors: Bayside Health; Bayside Health
Withdrawn - verified November 2009 - Condition: Influenza
Interventions: Biological: CSL Limited Influenza Virus Vaccine; Biological: CSL Limited Influenza Virus Vaccine; Biological: CSL Limited Influenza Virus Vaccine
Sponsors: CSL Limited; CSL Limited
Completed - verified August 2011 - Condition: Malaria
Intervention: Drug: GSK932121; Rosiglitazone; Rosuvastatin
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Terminated - verified February 2012 - Condition: Meningitis, Meningococcal
Interventions: Biological: meningococcal B rLP2086 vaccine.; Biological: meningococcal B rLP2086 vaccine.; Biological: meningococcal B rLP2086 vaccine.; Other: normal saline (placebo)
Sponsors: Pfizer; Pfizer
Active, not recruiting - verified April 2012 - Condition: Osteonecrosis
Interventions: Drug: Zoledronic Acid; Drug: Placebo
Sponsors: University of Sydney; University of Sydney; Novartis
Recruiting - verified February 2011 - Conditions: Liver Fibrosis; Heart Failure
Intervention: Device: FibroScan
Sponsors: Monash University; Monash University; The Alfred
Completed - verified July 2011 - Conditions: Alzheimer Disease; Amyloid Beta-Protein
Intervention: Drug: Florbetaben (BAY94-9172)
Sponsors: Bayer; Bayer
Completed - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Escitalopram; Drug: Sertraline; Drug: Venlafaxine XR
Sponsors: BRC Operations Pty. Ltd.; BRC Operations Pty. Ltd.
Recruiting - verified March 2012 - Condition: Heart Failure
Interventions: Drug: Urotensine II; Drug: Soluble epoxide hydrolase
Sponsors: Monash University; Monash University
Completed - verified July 2011 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Heart Failure
Interventions: Drug: Spironolactone; Drug: Placebo
Sponsors: Monash University; Monash University; National Heart Foundation, Australia
Recruiting - verified March 2012 - Condition: Influenza
Interventions: Biological: CSL Limited Influenza Vaccine; Biological: Placebo
Sponsors: CSL Limited; CSL Limited
Completed - verified August 2011 - Conditions: Diphtheria; Pertussis; Hepatitis A; Tetanus
Interventions: Biological: INFANRIX; Biological: BOOSTRIX; Biological: HAVRIX
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Terminated - verified September 2011 - Condition: Cardiovascular Disease
Intervention:
Sponsors: Monash University; Monash University
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: GSK679586; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified January 2012 - Condition: Heart Failure
Intervention: Behavioral: Early detection of heart failure
Sponsors: The Alfred; Henry Krum; HBA
Active, not recruiting - verified April 2012 - Condition: Prophylaxis for HPV Infections and Associated Cervical Neoplasia
Interventions: Biological: Cervarix; Biological: Placebo control
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified February 2012 - Condition: Herpes Simplex
Interventions: Biological: GSK208141; Biological: HavrixTM (investigational formulation); Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012 - Conditions: Hepatitis B; Hepatitis A
Interventions: Biological: Twinrix™ Adult; Biological: Twinrix™ Junior
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified November 2011 - Conditions: Hepatitis B; Hepatitis A
Intervention: Biological: Combined Hepatitis A and B vaccine
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified September 2011 - Conditions: Human Papillomavirus (HPV) Infection; Cervical Neoplasia
Interventions: Biological: Cervarix™; Biological: Havrix™-based investigational formulation
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Diabetes Mellitus, Type 1
Intervention:
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR); Juvenile Diabetes Research Foundation; American Diabetes Association
Recruiting - verified March 2012
 |
Join Clinical Trials for Healthy Volunteers in Victoria |
